From Concept to Commercialization,
We’ll be Your Guide

We integrate cutting-edge technologies, end-to-end capabilities, and the smartest people to regenerate cells, rewrite genes, and redefine manufacturing, right from the start.

ElevateBio is powering transformative cell and gene therapies today and for many decades to come.

BaseCamp: Where Scientific Visions Become Reality

BaseCamp houses a wide range of technologies, expertise, operations, processes, and GMP manufacturing under one roof, so our partners can accelerate the development of life-transforming cell and gene therapies, wherever they are in the product life cycle.

Explore BaseCamp

World-Class, Trail-Blazing Technologies

Our next-generation enabling technologies in gene editing, induced pluripotent stem cells (iPSCs), and cell, protein, and vector engineering equip partners with the tools they need to discover and develop an unprecedented array of potentially groundbreaking cell and gene therapies.

Learn More About Our Enabling Technologies

Gene Editing

Life Edit contains our highly innovative genome editing technology platform, with RNA-guided nucleases, base editors, and PAM diversity

Learn more about our gene editing capabilities

iPSCs

Setting a new standard with well characterized, clinical-grade iPSC lines to accelerate the development of iPSC-derived immunotherapies and regenerative medicines

Learn More

Cell, Protein, and Vector Engineering

Platforms that enable the construction and scaling of cell and gene therapies, with a focus on immunotherapies

Powering Partnerships

We work closely alongside our partners, empowering them with the tools and knowhow necessary to accelerate the creation of life changing therapies.

News & Media

Stay up-to-date with news from across the ElevateBio ecosystem.

Press Releases

ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene Therapy Innovation

August 25, 2022
Read moreRead more

ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines

August 23, 2022
Read moreRead more

ElevateBio Announces the Formation of a New Company with George Daley, M.D., Ph.D., and Boston Children’s Hospital to Develop iPSC-Derived Allogeneic Immune Therapies

August 4, 2022
Read moreRead more

Ready to Begin Your Journey?